Having trouble accessing articles? Reset your cache.

Anturol: Phase III data

Top-line data from a double-blind Phase III trial in 600 patients showed that 56 and 84 mg once-daily topical

Read the full 196 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE